Clinical Trial: Galectin-3 as a Biomarker in Patients With Chagas Disease

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: Validation of Galectin-3 as a Biomarker for Determining Patients Prognosis With Chagas Disease

Brief Summary: The purpose of this study is to analyze the efficacy of Galectin-3 as a biomarker on the Chagas Disease prognosis. This analysis will be done through the correlation between the plasmatic levels of this molecule with functional and laboratory tests.